Literature DB >> 20816695

Pandemic influenza A(H1N1) 2009 and respiratory syncytial virus associated hospitalizations.

Fernando Lovato-Salas1, Lorena Matienzo-Serment, César Monjarás-Ávila, Elizabeth E Godoy-Lozano, Andreu Comas-García, Marcela Aguilera-Barragán, Adriana Durham-González, Soledad Contreras-Vidales, Uciel Ochoa-Pérez, Alejandro Gómez-Gómez, Christian A García-Sepúlveda, Daniel E Noyola.   

Abstract

OBJECTIVES: To determine the contribution of influenza and respiratory syncytial virus (RSV) as the cause of lower respiratory tract infection (LRTI) associated hospitalizations during the first year of the influenza A(H1N1) 2009 pandemic and to assess the severity of illness during the second pandemic wave.
METHODS: Patients admitted with LRTI from April 2009 through March 2010 were assessed for the presence of influenza and RSV. Pandemic influenza virus was detected by means of a nested RT-PCR assay and/or the CDC's real time-PCR protocol. RSV was detected using a one-step RT-PCR assay. The characteristics of patients admitted during the first and second pandemic outbreaks were compared.
RESULTS: 657 patients with LRTI were admitted during the study period. Pandemic influenza virus was detected in 180 and RSV in 133. Influenza was the most common cause of infection in adults, while RSV was more common in children. There were no differences in disease severity between the first and second pandemic outbreaks.
CONCLUSIONS: Pandemic influenza virus was associated to increased numbers of hospitalizations and deaths; particularly in adults. The severity of the first and second pandemic outbreaks was similar. RSV continues to be the main pathogen responsible for hospitalizations in young children.
Copyright © 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816695     DOI: 10.1016/j.jinf.2010.08.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  Effect of the 2009 influenza A/H1N1 pandemic on viral respiratory infections in the first year of life.

Authors:  Linda C Ede; Michael J Loeffelholz; Pedro Alvarez-Fernandez; Dan L Pong; Janak A Patel; David P McCormick; Tasnee Chonmaitree
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

2.  A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.

Authors:  Tiffany M Turner; Les P Jones; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

3.  Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza.

Authors:  Vivek Charu; Gerardo Chowell; Lina Sofia Palacio Mejia; Santiago Echevarría-Zuno; Víctor H Borja-Aburto; Lone Simonsen; Mark A Miller; Cécile Viboud
Journal:  Clin Infect Dis       Date:  2011-10-05       Impact factor: 9.079

4.  In Vitro Inactivation of Respiratory Viruses and Rotavirus by the Oral Probiotic Strain Weissella cibaria CMS1.

Authors:  Mi-Sun Kang; Geun-Yeong Park
Journal:  Probiotics Antimicrob Proteins       Date:  2022-05-10       Impact factor: 5.265

5.  Risk factors for severe influenza A-related pneumonia in adult cohort, Mexico, 2013-14.

Authors:  Alejandro Gómez-Gómez; Martin Magaña-Aquino; Sofía Bernal-Silva; Javier Araujo-Meléndez; Andreu Comas-García; Emma Alonso-Zúñiga; Eliana Torres-Torres; Daniel E Noyola
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

6.  Challenges and opportunities in developing respiratory syncytial virus therapeutics.

Authors:  Eric A F Simões; John P DeVincenzo; Michael Boeckh; Louis Bont; James E Crowe; Paul Griffiths; Frederick G Hayden; Richard L Hodinka; Rosalind L Smyth; Keith Spencer; Steffen Thirstrup; Edward E Walsh; Richard J Whitley
Journal:  J Infect Dis       Date:  2015-03-15       Impact factor: 5.226

7.  Superinfection between influenza and RSV alternating patterns in San Luis Potosí State, México.

Authors:  Jorge Xicoténcatl Velasco-Hernández; Mayra Núñez-López; Andreu Comas-García; Daniel Ernesto Noyola Cherpitel; Marcos Capistrán Ocampo
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 8.  Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza.

Authors:  José María Navarro-Marí; Mercedes Pérez-Ruiz; Juan Carlos Galán Montemayor; María Ángeles Marcos Maeso; Jordi Reina; María de Oña Navarro; Carlos Gustavo Cilla Eguiluz
Journal:  Enferm Infecc Microbiol Clin       Date:  2012-10       Impact factor: 1.731

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.